A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.

Amy E MorrisonKimberley ChongPeter A SeniorAnna Lam

Published in: PloS one (2022)

There is extensive real-world data, but a lack of randomized control trial evidence supporting DIY AID system use, due to the user-driven, unregulated nature of these systems. Healthcare providers report a lack of understanding surrounding, and confidence in supporting, DIY AID despite impressive observational and user self-reported improvements in glycemic variability, without any reported safety compromises.

Keyphrases

type diabetes
healthcare
glycemic control
open label
machine learning
double blind
electronic health record
deep learning
high throughput
placebo controlled
phase iii
randomized controlled trial
cross sectional
adipose tissue
skeletal muscle
weight loss
health insurance
single cell